Pulmonary Arterial Hypertension (or PAH) is a rare and progressive form of lung disease resulting from the gradual narrowing and restriction of blood flow through the pulmonary arteries, which stretch between the heart and the lungs.
As blood flow is restricted, blood pressure in the pulmonary arteries spike, straining the right vertical of the heart and causing weakness, lack of blood flow, inflammation, and eventual heart failure.
These eight medicinal and surgical treatment options for PAH are based on a variety of medical detail—including age, medical history, cause, lifestyle, overall health, and other existing health conditions—and may be used in combination…
Blood thinning medications, or anticoagulants, are commonly prescribed to PAH patients to increase blood flow as well as lower the risk of blood clot formation in the blood vessels. Common blood thinners recommended by doctors are warfarin sodium (or Coumadin). However, patients taking this therapy will be monitored for bleeding complications at a lab regularly.